Methodological Issues in the Design and Analyses of Neonatal Research Studies: Experience of the NICHD Neonatal Research Network

Overview

Journal Semin Perinatol

Specialty Gynecology & Obstetrics

Date 2016 Jun 27

PMID 27344192

Citations 5

Authors

Abhik Das

Jon Tyson

Claudia Pedroza

Barbara Schmidt

Marie Gantz

Dennis Wallace

William E Truog

Rosemary D Higgins

Affiliations

Soon will be listed here.

Abstract

Impressive advances in neonatology have occurred over the 30 years of life of The Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN). However, substantial room for improvement remains in investigating and further developing the evidence base for improving outcomes among the extremely premature. We discuss some of the specific methodological challenges in the statistical design and analysis of randomized trials and observational studies in this population. Challenges faced by the NRN include designing trials for unusual or rare outcomes, accounting for and explaining center variations, identifying other subgroup differences, and balancing safety and efficacy concerns between short-term hospital outcomes and longer-term neurodevelopmental outcomes. In conclusion, the constellation of unique patient characteristics in neonates calls for broad understanding and careful consideration of the issues identified in this article for conducting rigorous studies in this population.

Citing Articles

Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS).

Chock V, Kirpalani H, Bell E, Tan S, Hintz S, Ball M JAMA Netw Open. 2023; 6(9):e2334889.

PMID: 37733345 PMC: 10514737. DOI: 10.1001/jamanetworkopen.2023.34889.

Perinatal epidemiology: Issues, challenges, and potential solutions.

Giannakou K Obstet Med. 2021; 14(2):77-82.

PMID: 34394715 PMC: 8358245. DOI: 10.1177/1753495X20948984.

Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative.

Sanz J, Anixt J, Bear L, Basken A, Beca J, Marino B Cardiol Young. 2021; 31(6):876-887.

PMID: 34082845 PMC: 8429101. DOI: 10.1017/S1047951121002146.

In-hospital mortality and morbidity among extremely preterm infants in relation to maternal body mass index.

Chawla S, Laptook A, Smith E, Tan S, Natarajan G, Wyckoff M J Perinatol. 2020; 41(5):1014-1024.

PMID: 33024258 PMC: 8021608. DOI: 10.1038/s41372-020-00847-0.

Association between the p.Thr1406Asn polymorphism of the carbamoyl-phosphate synthetase 1 gene and necrotizing enterocolitis: A prospective multicenter study.

Moonen R, Cavallaro G, Huizing M, Gonzalez-Luis G, Mosca F, Villamor E Sci Rep. 2016; 6:36999.

PMID: 27833157 PMC: 5105130. DOI: 10.1038/srep36999.

References

DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

Lilford R, Thornton J, Braunholtz D . Clinical trials and rare diseases: a way out of a conundrum. BMJ. 1995; 311(7020):1621-5. PMC: 2551510. DOI: 10.1136/bmj.311.7020.1621. View

Tyson J, Pedroza C, Langer J, Green C, Morris B, Stevenson D . Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns?. J Perinatol. 2012; 32(9):677-84. PMC: 3558278. DOI: 10.1038/jp.2012.64. View

Pedroza C, Han W, Truong V, Green C, Tyson J . Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study. Stat Methods Med Res. 2015; 27(1):79-96. DOI: 10.1177/0962280215620828. View

Morris B, Oh W, Tyson J, Stevenson D, Phelps D, OShea T . Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med. 2008; 359(18):1885-96. PMC: 2821221. DOI: 10.1056/NEJMoa0803024. View

Yelland L, Sullivan T, Makrides M . Accounting for multiple births in randomised trials: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2014; 100(2):F116-20. DOI: 10.1136/archdischild-2014-306239. View

Fischer N, Steurer M, Adams M, Berger T . Survival rates of extremely preterm infants (gestational age <26 weeks) in Switzerland: impact of the Swiss guidelines for the care of infants born at the limit of viability. Arch Dis Child Fetal Neonatal Ed. 2009; 94(6):F407-13. DOI: 10.1136/adc.2008.154567. View

Marcucci M, Sinclair J . A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials. BMJ Open. 2013; 3(8). PMC: 3752048. DOI: 10.1136/bmjopen-2013-003143. View

Truog W, Nelin L, Das A, Kendrick D, Bell E, Carlo W . Inhaled nitric oxide usage in preterm infants in the NICHD Neonatal Research Network: inter-site variation and propensity evaluation. J Perinatol. 2014; 34(11):842-6. PMC: 4323079. DOI: 10.1038/jp.2014.105. View

10.

Spiegelhalter D, Myles J, Jones D, Abrams K . Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ. 1999; 319(7208):508-12. PMC: 1116393. DOI: 10.1136/bmj.319.7208.508. View

11.

Ehrenkranz R, Das A, Wrage L, Poindexter B, Higgins R, Stoll B . Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res. 2011; 69(6):522-9. PMC: 3090495. DOI: 10.1203/PDR.0b013e318217f4f1. View

12.

Bernardo J, Nowacki A, Martin R, Fanaroff J, Hibbs A . Multiples and parents of multiples prefer same arm randomization of siblings in neonatal trials. J Perinatol. 2014; 35(3):208-13. PMC: 4835691. DOI: 10.1038/jp.2014.192. View

13.

Walter S, Sinclair J . Uncertainty in the minimum event risk to justify treatment was evaluated. J Clin Epidemiol. 2009; 62(8):816-24. DOI: 10.1016/j.jclinepi.2008.09.017. View

14.

Stoll B, Hansen N, Bell E, Walsh M, Carlo W, Shankaran S . Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA. 2015; 314(10):1039-51. PMC: 4787615. DOI: 10.1001/jama.2015.10244. View

15.

Greenland S . Putting background information about relative risks into conjugate prior distributions. Biometrics. 2001; 57(3):663-70. DOI: 10.1111/j.0006-341x.2001.00663.x. View

16.

Sinclair J . Weighing risks and benefits in treating the individual patient. Clin Perinatol. 2003; 30(2):251-68. DOI: 10.1016/s0095-5108(03)00023-x. View

17.

Chen Y . Maximum likelihood analysis of semicompeting risks data with semiparametric regression models. Lifetime Data Anal. 2011; 18(1):36-57. DOI: 10.1007/s10985-011-9202-4. View

18.

Carlo W, Finer N, Walsh M, Rich W, Gantz M, Laptook A . Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010; 362(21):1959-69. PMC: 2891970. DOI: 10.1056/NEJMoa0911781. View

19.

Chen Y, DeMets D, Lan K . Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis. Control Clin Trials. 2003; 24(1):16-27. DOI: 10.1016/s0197-2456(02)00306-9. View

20.

Stark A, Carlo W, Tyson J, Papile L, Wright L, Shankaran S . Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001; 344(2):95-101. DOI: 10.1056/NEJM200101113440203. View